Strong Start for Mothers and Newborns

 

The Centers for Medicare and Medicaid Services (CMS), Center for Medicare and Medicaid Innovation (Innovation Center), is interested in testing new care and payment models that have the potential to improve perinatal outcomes for women enrolled in Medicaid or CHIP who are at high-risk for adverse pregnancy outcomes.

Deleted 04/02/2020 (Archived.) 93.611 Agency: Department of Health and Human Services
Office: Centers for Medicare and Medicaid Services Cooperative Agreements Not Applicable. The Patient Protection and Affordable Care Act, Public Law 111-148, Section 3021, Innovation Center Authority. The target applicants for this solicitation are providers (e.g., specific service providers, clinician groups and/or hospitals); States applying in partnership with providers; managed care organizations (MCOs) applying in partnership with providers; and conveners applying in partnership with providers. All applicants not directly providing prenatal care services (i.e. States, MCOs, and conveners) are expected to partner with providers of obstetrical care services and proposed enhanced prenatal care services. Included within the definition of State, for the purposes of this FOA are the District of Columbia and the 5 U.S. Territories: American Samoa, Guam, Northern Mariana Islands, Puerto Rico, and the U.S. Virgin Islands. Faith-based organizations, Community-based organizations, and Tribal organizations are also eligible to apply.

States, managed care organizations, and conveners must include letters of agreement from their provider partners who will be carrying out the intervention as described in the proposal. Partnerships with public health organizations are encouraged, as are multi-state collaborations. Women enrolled in Medicaid and/or CHIP. Not Applicable. 2 CFR 200, Subpart E - Cost Principles applies to this program. Preapplication coordination is not applicable. Environmental impact information is not required for this program. This program is excluded from coverage under E.O. 12372. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. OMB Circular No. A-102 applies to this program. OMB Circular No. A-110 applies to this program. The standard application form SF-424 and related forms must be used for this program. Applicants should review the application and submission information in the Funding Opportunity Announcement (FOA) for specific instructions on applying for this cooperative agreement program. CMS will make a decision for each application received. Each applicant will receive written notification of CMS' decision. Applicants approved for an award must submit a letter of acceptance to CMS within 30 days of the date of the award, agreeing to the terms and conditions of the award. Contact the headquarters or regional office, as appropriate, for application deadlines. From 60 to 90 days. Not Applicable. Cooperative agreements include three years of service delivery and an additional year for data reporting requirements on births of intervention infants. The awardee must annually submit a formal request for continuation accompanied by a progress report which will be evaluated prior to a recommendation of continuation. Upon notification of the award, awardees will receive initial funding for the first year or 12-months of their program, to be used for implementation of the proposed intervention. Non-competing continuation awards will be awarded for each additional year of the award, contingent upon availability of funding, awardee performance, and demonstrated progress toward the goal of reducing premature births. Applicant should refer to the funding opportunity announcement under this CFDA program for specific criteria requirements on proposal selection. Cooperative agreement awards made to successful applicants will be provided to augment and coordinate with pre-existing State-provided prenatal care services and benefits to test whether more comprehensive prenatal care services, as are to be enabled in these awards, lead to better birth outcomes for high risk women and infants, per inclusion in a rigorous evaluation study framework and program improvement initiative. States may not use funds as the State's share of the Medicaid program costs or as supplemental Disproportionate Share Hospital (DSH) payments. This funding may not be duplicative of other Federal funding opportunities for information technology capacity building such as assistance provided through Medicaid, ARRA, HITECH, ONC or other CMS initiatives. The intent of this proposal is to complement, not supplant any of these or other Federal programs. States may not use funds as the State's share of the Medicaid program costs or as supplemental Disproportionate Share Hospital (DSH) payments. This funding may not be duplicative of other Federal funding opportunities for information technology capacity building such as assistance provided through Medicaid, ARRA, HITECH, ONC or other CMS initiatives. The intent of this proposal is to complement, not supplant any of these or other Federal programs. Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements. Submit a quarterly electronic Federal Financial Report (FFR) via the Payment Management System. The quarterly report identifies cash transactions against the authorized funds for the cooperative agreement. The FFR Cash Transaction Reports must be filed within 30 days of the end of each quarter. Failure to submit the report may result in the inability to access cooperative agreement funds. Go to - www.dpm.psc.gov for additional information. The final FFR, including both cash transactions and expenditures, must be submitted and received within 90 days of the end of the project period. Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements. Grantees must include expenditures on the annual FFR (submitted at the end of each budget period). The final FFR must be submitted within 90 days after the end of the project period end date and include both cash transactions and expenditures data. No performance monitoring is required. Submit a quarterly electronic Federal Financial Report (FFR) via the Payment Management System. The quarterly report identifies cash transactions against the authorized funds for the cooperative agreement. The FFR Cash Transaction Reports must be filed within 30 days of the end of each quarter. Failure to submit the report may result in the inability to access cooperative agreement funds. Go to - www.dpm.psc.gov for additional information. The final FFR, including both cash transactions and expenditures, must be submitted and received within 90 days of the end of the project period. Applicants should review the individual funding opportunity announcement for information on programmatic and evaluation reporting requirements. Grantees must include expenditures on the annual FFR (submitted at the end of each budget period). The final FFR must be submitted within 90 days after the end of the project period end date and include both cash transactions and expenditures data. No performance monitoring is required. In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. Proper accounting records, identifiable by project number including all receipts and expenditures must be maintained for 3 years. Subsequent to audit, they must be maintained until all questions are resolved. This program has no statutory formula.
Matching requirements are not applicable to this program.
MOE requirements are not applicable to this program. Cooperative agreements are generally funded on a 12-month basis, with support beyond the first year contingent upon acceptable evidence of satisfactory progress, continuing program relevance, and availability of funds. See the following for information on how assistance is awarded/released: Successful applicants will receive a Notice of Award. Unsuccessful applicants will be notified by letter. Applicants should review the award administration information in the funding opportunity announcement issued under this CFDA program for more information. See the following for information on how assistance is awarded/released: Successful applicants will receive a Notice of Award. Unsuccessful applicants will be notified by letter. Applicants should review the award administration information in the funding opportunity announcement issued under this CFDA program for more information. See Regional Agency Offices. Michelle T. Feagins, Centers for Medicare and Medicaid Services, Office of Acquisition and Grants Management (OAGM), 200 Independence Ave, SW, Room 733H-02, Washington DC 20201. Michelle T. Feagins Centers for Medicare and Medicaid Services
Office of Acquisition and Grants Management
200 Independence Ave., SW
Room 733H-02, Washington, District of Columbia 20201 Email: michelle.feagins@cms.hhs.gov Phone: 301-492-4312 http://innovations.cms.gov/initiatives/Strong-Start/index.html 75-0522-0-1-551. (Cooperative Agreements) FY 14 $11,820,172; FY 15 est $11,774,223; and FY 16 est $0 - N/A. Approximately $41.4 million may be awarded over the four-year period of performance (overlapping FFY 2013 into FFY 2016) to implement the approved models. This includes a three year period for service delivery and up to an additional year for data collection and submission. There were 27 awards in FY 2013, ranging from $190,000 to $1,600,000 with an average award of $436,000. Applicants should refer to the funding opportunity announcement for applicable regulations, guidelines and literature. Not Applicable.